Citius Pharmaceuticals (CTXR) Asset Utilization Ratio (2025 - 2026)

Citius Pharmaceuticals' (CTXR) quarterly Asset Utilization Ratio came in at 0.05 in Q2 2026, up 25.76% quarter-over-quarter from 0.04 in Q1 2026.

Analysis

Citius Pharmaceuticals (CTXR) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

Citius Pharmaceuticals (CTXR) has reported Asset Utilization Ratio for 2 consecutive years, with 0.05 the latest figure, recorded in Q2 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Johnson & Johnson	640.34 Bn	619.59 Bn	17.26 Bn	0.49
2	AbbVie	445.94 Bn	439.37 Bn	12.70 Bn	0.47
3	Merck	356.80 Bn	349.66 Bn	12.21 Bn	0.52
4	Novartis Ag	269.15 Bn	261.46 Bn	11.24 Bn	0.57
5	Pfizer	156.49 Bn	144.80 Bn	10.94 Bn	0.31
6	Sanofi	52.18 Bn	44.80 Bn	10.79 Bn	0.36
7	Revolution Medicines	43.29 Bn	43.29 Bn	-	-
8	Incyte	24.98 Bn	20.44 Bn	1.57 Bn	0.77
9	United Therapeutics	21.33 Bn	18.67 Bn	683.80 Mn	0.45
10	Citius Pharmaceuticals	15.36 Mn	15.36 Mn	1.00 Mn	0.05

Historic Data

Download Data